Coronavirus Live Count Map India
remove_red_eye 545 Views
COVID-19 Vaccine Updates
#Business And Medicine #Emergency Medicine #Infectious Diseases #Pathology and Lab Medicine #Pharmacist #Public Health #Pulmonary Medicine
Johnson & Johnson has sought U.S. health regulator’s authorization for its COVID-19 vaccine for emergency use. The company will also apply for authorization to European authorities in the ensuing weeks.
The application for emergency use authorization comes after a January 29 global trial report which stated that the vaccine had a 66% efficacy in preventing COVID-19 infection. The U.S. Food and Drug Administration (FDA) has stated that a meeting of its Vaccines and Related Biological Products Advisory Committee has been scheduled for February 26, where the drugmaker’s application for emergency use authorization will be discussed. The J&J vaccine is a single-shot vaccine and does not need to be shipped frozen, unlike the Pfizer-BioNTech and Moderna vaccines… (Reuters, February 5, 2021)
To comment on this article,
create a free account.
Already registered?
.jpg)
